Pharmaceutical ERP Consultant, USA

Manufacturer, virtual sponsor or wholesaler: where the lot record lives

The first question in any US pharmaceutical ERP project is not which software to buy. It is where each piece of the lot story is recorded. A company with its own plant creates the batch, tests it and releases it under its own quality system. A virtual sponsor never touches the product: a contract manufacturer makes it, a contract lab tests it, and a 3PL stores and ships it. A wholesaler receives finished lots from many manufacturers and sells to pharmacies, clinics and other distributors.

Each model needs a different ERP design. For a sponsor, the ERP mostly mirrors events that happen at partners, so the real work is in the data feeds: certificate of analysis received, lot released by QA, receipt at the 3PL, shipment confirmed. For a wholesaler, the hard parts are receiving with lot and expiry captured correctly, holding suspect or returned product apart, and picking by expiry. For a manufacturer, all of this plus batch orders, yield and costing.

I map these flows with operations, finance and quality in the same session, marking every status change and who is allowed to make it. The general pattern is described on my pharmaceutical ERP page. If you also run a broader production operation, my US manufacturing ERP page covers costing, tariffs and plant economics, which I do not repeat here.

Product tracing and serialization: what the ERP holds and what it hands off

Federal product tracing requirements for prescription drugs expect trading partners to exchange transaction information and, increasingly, to identify product down to the serialized unit. In most mid-sized companies, the ERP is not where serial numbers are generated or stored. That usually sits in a dedicated serialization or tracing platform connected to packaging lines and to trading partner networks.

What the ERP must do is supply clean, consistent data to that platform. In requirements terms, that means:

• Product master data with the identifiers your packaging and tracing tools expect, kept under change control.
• Lot and expiry captured at receipt or batch completion, never typed in later from paper.
• Ship-to and sold-to records that match what trading partners hold, including license references.
• Clear events, such as goods issue or return receipt, that trigger messages to the tracing platform, with error handling when a message fails.
• A way to quarantine returned or suspect product until it is verified.

Which obligations apply to your business, and how, is for your regulatory team and their advisors to decide. My part is to write the interface specification so the ERP and the tracing platform agree on every field, and to test it with real scenarios during UAT. Interface design itself follows my ERP integration approach.

Chargebacks, wholesaler fees and the real net price

US pharmaceutical revenue is rarely the invoice price. A manufacturer typically sells to a wholesaler at a list price, the wholesaler resells to a pharmacy, clinic or group under a contract price, and then claims the difference back as a chargeback. On top of that come distribution service fees, prompt payment discounts, returns credits and, for some products, rebates paid to other parties.

If the ERP only records the invoice, finance spends every close reconciling chargeback files against contracts in spreadsheets, and product margins look better than they are. The requirements I write cover:

• Contract price lists linked to eligible customers, with start and end dates.
• Import and validation of chargeback claims, with rejection of claims that do not match a valid contract.
• Accruals for expected chargebacks, fees and returns, so revenue is booked net in the right period.
• Credit memos to wholesalers with a clear audit trail back to each claim line.
• Reporting of gross-to-net by product, customer class and period.

Some companies handle this in a specialist contract management tool and post results to the ERP. Others keep it in the ERP itself. I help you decide based on contract volume and complexity, and the decision goes into the fit-gap during ERP evaluation. Accounting treatment is confirmed with your auditors, not by me.

State licenses, controlled substances and the QMS boundary

Distributors and manufacturers shipping across the country deal with licensing at both federal and state level, and the rules differ from state to state. In ERP terms, that becomes master data: the license number, type, state and expiry date for your own facilities and for each customer ship-to address. With that data in place, the system can warn or block when an order is going to a location without a current license on file. What counts as acceptable is a rule your compliance lead sets; I make sure the system can enforce it.

Controlled substances add record keeping obligations around ordering, receipt, storage, dispensing to customers and losses. Some businesses manage these records in a specialist module; others extend the ERP. Either way, I define which transactions need extra approval, which reports the compliance team relies on, and how inventory adjustments are restricted.

Equally important is what the ERP should not do. Deviation handling, CAPA, change requests, training and controlled documents usually belong in a quality management system. Sample results and specifications live in a LIMS. The ERP needs the outcome: a lot status of released, rejected or on hold, updated by an authorized person or interface. Drawing that line early stops an implementer from building a weak QMS inside the ERP, and it gives your QA team a smaller, clearer scope when they decide what validation the FDA context calls for.

Platforms, migration and remote delivery for US pharma teams

US pharmaceutical companies commonly start from QuickBooks or an older on-premise system, with lot data in spreadsheets and quality records elsewhere. Moving to a new ERP means migrating open lots with their status and remaining shelf life, open purchase orders with suppliers and contract manufacturers, open sales contracts and chargeback history, and the customer license file. I plan that with a migration checklist and reconciliation steps, so the first post-go-live inventory count matches what quality believes is releasable.

Platform choice depends on whether you manufacture, how complex your pricing is, and how much the system must integrate with tracing, QMS and 3PL tools. The platform notes on this page summarize where each option tends to fit. For a wider view of US engagements beyond pharma, see my ERP consultant USA page and the United States hub.

All of the work runs remotely: video workshops, shared process maps, a numbered requirements document, a fit-gap matrix and recorded UAT sessions. I schedule sessions to suit your teams across US time zones, and a warehouse or packaging area can be walked through on a live video call. If being there in person would genuinely help, we can agree it by arrangement, but nothing in the plan relies on it.